DNDI-6148

N/A

Report date: 2022/12/05 10:56:55
NME

Base Information

Drug NameDNDI-6148
Drug Alias NameDNDI-6148
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCleavage and polyadenylation specificity factor subunit 3 inhibitors
TargetsCleavage and polyadenylation specificity factor subunit 3
Therapy Area/IndicationsLeishmaniasis, VisceralLeishmaniasis, CutaneousInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDrugs For Neglected Diseases Initiative
China Registration ClassN/A

Develop Information

Active CompaniesDrugs For Neglected Diseases Initiative
Inactive CompaniesN/A
Active IndicationsLeishmaniasis, VisceralLeishmaniasis, Cutaneous
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A